Heer Medical Technology Development Co. Ltd.
Records under this name other than the patents Heer Medical Technology Development Co. Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 7 of 7 · Back to Heer Medical Technology Development Co. Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,865,162 | Novel monoclonal antibodies against HPV proteins Lapsed on the fee record Ended Oct 21, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 21, 2026 | Low confidence |
| US 8,859,218 | In Situ Detection of Early Stages and Late Stages HPV Infection Lapsed on the fee record Ended Oct 14, 2026 · High confidence | Lapsed on the fee record | Ended Oct 14, 2026 | High confidence |
| US 8,278,056 | Detection of early stages and late stages HPV infection Lapsed on the fee record Ended Oct 2, 2024 · USPTO record | Lapsed on the fee record | Ended Oct 2, 2024 | USPTO record |
| US 9,128,094 | High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers Lapsed on the fee record Ended Sep 8, 2023 · USPTO record | Lapsed on the fee record | Ended Sep 8, 2023 | USPTO record |
| US 7,972,776 | Protein chips for HPV detection Lapsed on the fee record Ended Jul 5, 2023 · USPTO record | Lapsed on the fee record | Ended Jul 5, 2023 | USPTO record |
| US 9,568,474 | In Situ Detection of Early Stages and Late Stages HPV Infection Lapsed on the fee record Ended Feb 14, 2021 · High confidence | Lapsed on the fee record | Ended Feb 14, 2021 | High confidence |
| US 7,732,166 | Detection method for human pappilomavirus (HPV) and its application in cervical cancer Lapsed on the fee record Ended Jun 8, 2018 · USPTO record | Lapsed on the fee record | Ended Jun 8, 2018 | USPTO record |